[1] Aruna DP, JoAnn E, Manson,et al. C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus [J] . JAMA,2001, 286(3) : 327-334.[2] Bloommgarden ZT. Inflammztion and insulin resistance [J] . Diabetes Care, 2003, 26 : 1619-1623.[3] Pradhan AD, Manson JE, Rifai N, et al. The relation of markers of inflammation to the development of glucose disorders in the elderly: the cardiovascular health study [J] . JAMA, 2001, 286 : 327-334.[4] Sourris KC, Forbes JM. Interactions between advanced glycation end-products (AGE) and their receptors in the development and progression of diabetic nephropathy - are these receptors valid therapeutic targets [J] . Curr Drug Targets, 2009, 10 (1) : 42-50.[5] 石燕,戴晓莉,薛渊,等. 小鼠高迁移率族蛋白1cDNA克隆、原核表达与鉴定[J] . 江苏大学学报(医学版),2009, 19(3) :230-232.[6] Association of Diabetes and Pregnancy.International association of diabetes and pregnancy study groups recommendations on the diagnosis and classification of hyperglycemia in pregnancy: international association of diabetes and pregnancy study groups consensus panel [J] . Diabetes Care,2010,3(33) : 3676-3682.[7] Bell CW, Jiang W, Reich CF,et al.The extracellular release of HMGB1 during apoptotic cell death [J] . J Physiol Cell Physiol, 2006, 291 : 1318-1325.[8] Hreggvidsdottir HS,Ostberg T,Wähämaa H, et al. The alarmin HMGB1 acts in synergy with endogenous and exogenous danger signals to promote inflammation [J] . J Leukoc Biol, 2009, 86 : 655-662.(2014-01-10收稿 2014-04-15修回) |